Lv3
290 积分 2023-07-04 加入
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
30天前
已完结
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field
2个月前
已完结
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
2个月前
已完结
Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1alpha
2个月前
已完结
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
2个月前
已完结
Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules
2个月前
已完结
Prostate Cancer
5个月前
已完结
The development of androgen-independent prostate cancer
5个月前
已完结
Legionella effector LnaB is a phosphoryl AMPylase that impairs phosphosignalling
5个月前
已完结
Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer
6个月前
已完结
皖公网安备34019202002308
